White Paper

A Molecule's Journey: Break Down Roadblocks To Commercial Manufacturing Success

By Christian Cattaruzza, Steven Strubbe, Laure Valognes, Corinne Lavie-Cambot, Laetitia Botrel, and Muriel Richard, BioRelianceĀ® End-to-End Solution

Laboratory bioprocess iStock-1144377258

Selection and implementation of a commercial manufacturing strategy that will ensure long term success is among the most critical decisions a biopharmaceutical company will make.

Every drug is unique and there are many options and factors to consider when it comes to identifying the best approach to commercial GMP manufacturing. The right strategy must align with your organizational objectives and be cost-effective, deliver the necessary quantity of drug substance, reduce risk and meet regulatory expectations. In this guidebook, our experts share key considerations for biopharmaceutical companies as they advance to commercial manufacturing and navigate complexities associated with business planning, process scale-up, optimization and validation, technology considerations and regulatory compliance.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: